People with schizophrenia are more likely to develop chronic obstructive pulmonary disease (COPD), suggesting a possible syndemic relationship between the two diseases, in addition to people not ...

Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...

Please provide your email address to receive an email when new articles are posted on . Dupilumab and mepolizumab are the only FDA-approved biologics for adults with COPD and an eosinophilic phenotype ...

“This new COPD diagnostic schema, which includes chest imaging, respiratory symptoms and spirometry, identified additional individuals at risk of poor respiratory outcomes,” said Bhatt, a professor in ...

For some patients with chronic obstructive pulmonary disease (COPD), summer can be one of the most stressful times of the year. Not only is allergy season in full swing, but rising temperatures and ...

Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...

Previous research has prompted warnings from North American and European health agencies of severe exacerbations associated with gabapentinoid use by patients with COPD. The researchers compared data ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken a hit after the anti-ST2 monoclonal antibody failed to reduce flare-ups in ...

PALO ALTO, Calif. & SAN FRANCISCO--(BUSINESS WIRE)--Stanford Health Care, one of the nation's leading academic medical centers, tapped Kivo Health as part of a collaboration to advance AI-powered ...

Biologic medicines are making inroads into chronic obstructive pulmonary disease (COPD), with two blockbuster antibodies expanding their FDA-approved uses to this lung disorder in the past year. A ...